Guardant Health
GH
#1003
Rank
HK$187.21 B
Marketcap
HK$1,395
Share price
1.75%
Change (1 day)
185.32%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -HK$3.56 Billion

According to Guardant Health 's latest financial reports the company's current earnings are HK$1.18 Billion. In 2025 the company made an earning of -HK$3.28 Billion, an increase over its 2024 earnings that were of -HK$3.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$3.56 Billion8.36%
2025 -HK$3.28 Billion-4.03%
2024 -HK$3.42 Billion-9.12%
2023 -HK$3.76 Billion-26.73%
2022 -HK$5.13 Billion69.96%
2021 -HK$3.02 Billion56.35%
2020 -HK$1.93 Billion252.69%
2019 -HK$0.55 Billion-17.22%
2018 -HK$0.67 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-HK$70.28 Million-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$1.99 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA